Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-001993
Filing Date
2022-01-05
Accepted
2022-01-05 19:23:01
Documents
2
Period of Report
2022-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1550
2 POA DOCUMENT poa.txt EX-24 4755
  Complete submission text file 0001209191-22-001993.txt   7681
Mailing Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102 (206) 737-0085
Icosavax, Inc. (Issuer) CIK: 0001786255 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ICOSAVAX, INC. 1616 EASTLAKE AVENUE E. SUITE 208 SEATTLE WA 98102
Business Address
Shiver John W. (Reporting) CIK: 0001900372 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40655 | Film No.: 22513095